跳至主要内容
临床试验/NCT05171426
NCT05171426已完成不适用

Incidental Cancer in Colectomy Specimens From Patients With Familial Adenomatous Polyposis

Dr. Ersin Arslan Education and Training Hospital1 个研究点 分布在 1 个国家目标入组 55 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
55
试验地点
1
主要终点
incidental cancer

研究概览

简要总结

Colectomy is life-saving in patients with familial adenomatous polyposis (FAP) because cancer development is inevitable in individuals with this disease. In this study, we aimed to determine the incidence of incidental malignancy in surgical specimens from patients who underwent colectomy for FAP. Prophylactic colectomy should be performed in patients with FAP, as colorectal cancer transformation is inevitable in these individuals. The possibility of incidental cancer identified via histopathological analysis of colectomy specimens should be kept in mind in these patients.

详细描述

Colectomy is life-saving in patients with familial adenomatous polyposis (FAP) because cancer development is inevitable in individuals with this disease. In this study, we aimed to determine the incidence of incidental malignancy in surgical specimens from patients who underwent colectomy for FAP. The files of patients diagnosed with FAP who underwent surgery in our clinic between 2010 and 2020 were retrospectively reviewed. Definitive surgery was performed in patients with histopathological malignancy identified in colonoscopic biopsies in the preoperative period, while prophylactic surgery was performed in patients without malignancy. The incidence of incidental malignancy in histopathological specimens from patients who underwent prophylactic colectomy was determined. Prophylactic colectomy should be performed in patients with FAP, as colorectal cancer transformation is inevitable in these individuals. The possibility of incidental cancer identified via histopathological analysis of colectomy specimens should be kept in mind in these patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • diagnosed with Familial Adenomatous Polyposis

排除标准

  • did not receive surgical treatment
  • data deficiencies

结局指标

主要结局

incidental cancer

时间窗: 2 or 3 week

Familial Adenomatous Polyposis with cancer

次要结局

未报告次要终点

研究者

发起方
Dr. Ersin Arslan Education and Training Hospital
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Ufuk Uylas

Primary investigator

Tepecik Training and Research Hospital

研究点 (1)

Loading locations...

相似试验